Randomized controlled trial comparing carbetocin, misoprostol, and oxytocin for the prevention of postpartum hemorrhage following an elective cesarean delivery. (öffnet neues Fenster)

Elbohoty AE, Mohammed WE, Sweed M, Bahaa Eldin AM, Nabhan A, Abd-El-Maeboud KH.

Quelle‎: Int J Gynaecol Obstet 2016;134(3):324-8.

Indiziert‎: PubMed 27350226

https://www.ncbi.nlm.nih.gov/pubmed/27350226 (öffnet neues Fenster)

Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. (öffnet neues Fenster)

Gallos ID, Williams HM, Price MJ, Merriel A, Gee H, Lissauer D, Moorthy V, Tobias A, Deeks JJ, Widmer M, Tunçalp Ö, Gulmezoglu AM, Hofmeyr GJ, Coomarasamy A

Quelle‎: Cochrane Database Syst Rev 2018;4:CD011689.

Indiziert‎: PubMed 29693726

DOI‎: 10.1002/14651858.CD011689.pub2

https://www.ncbi.nlm.nih.gov/pubmed/29693726 (öffnet neues Fenster)

Preventing postpartum hemorrhage after cesarean delivery: A network meta-analysis of available pharmacologic agents. (öffnet neues Fenster)

Jaffer D, Singh PM, Aslam A, Cahill AG, Palanisamy A, Monks DT

Quelle‎: Am J Obstet Gynecol.

Indiziert‎: PubMed 34534498

DOI‎: 10.1016/j.ajog.2021.08.060

https://pubmed.ncbi.nlm.nih.gov/34534498/ (öffnet neues Fenster)

A randomised controlled trial comparing oxytocin and oxytocin + ergometrine for prevention of postpartum haemorrhage at caesarean section. (öffnet neues Fenster)

Koen S, Snyman LC, Pattinson RC, Makin JA.

Quelle‎: S Afr Med J 2016;106(4):399-402.

Indiziert‎: PubMed 27032858

https://www.ncbi.nlm.nih.gov/pubmed/27032858 (öffnet neues Fenster)

Prophylactic use of ergot alkaloids in the third stage of labour. (öffnet neues Fenster)

Liabsuetrakul T, Choobun T, Peeyananjarassri K, Islam QM.

Quelle‎: Cochrane Database Syst Rev 2007;(2):CD005456.

Indiziert‎: PubMed 17443592

https://www.ncbi.nlm.nih.gov/pubmed/17443592 (öffnet neues Fenster)

Treatment for primary postpartum haemorrhage. (öffnet neues Fenster)

Mousa HA, Blum J, Abou El Senoun G, Shakur H, Alfirevic Z.

Quelle‎: Cochrane Database Syst Rev 2014;(2):CD003249.

Indiziert‎: PubMed 24523225

https://www.ncbi.nlm.nih.gov/pubmed/24523225 (öffnet neues Fenster)

Comparison of two oxytocin regimens to prevent uterine atony at cesarean delivery: a randomized controlled trial. (öffnet neues Fenster)

Munn MB, Owen J, Vincent R, Wakefield M, Chestnut DH, Hauth JC.

Quelle‎: Obstet Gynecol 2001;98(3):386-90.

Indiziert‎: PubMed 11530117

https://www.ncbi.nlm.nih.gov/pubmed/11530117 (öffnet neues Fenster)

Prospective randomized trial of oxytocin administration for active management of the third stage of labor. (öffnet neues Fenster)

Oguz Orhan E, Dilbaz B, Aksakal SE, Altınbas S, Erkaya S.

Quelle‎: Int J Gynaecol Obstet 2014;127(2):175-9.

Indiziert‎: PubMed 25108586

https://www.ncbi.nlm.nih.gov/pubmed/25108586 (öffnet neues Fenster)

A randomized clinical trial of preoperative versus postoperative misoprostol in elective cesarean delivery. (öffnet neues Fenster)

Ragab A, Barakat R, Alsammani MA.

Quelle‎: Int J Gynaecol Obstet 2016;132(1):82-4.

Indiziert‎: PubMed 26522140

DOI‎: 10.1016/j.ijgo.2015.06.057

https://www.ncbi.nlm.nih.gov/pubmed/26522140 (öffnet neues Fenster)

Dose and duration of oxytocin to prevent postpartum hemorrhage: a review. (öffnet neues Fenster)

Roach MK, Abramovici A, Tita AT.

Quelle‎: Am J Perinatol 2013;30(7):523-8.

Indiziert‎: PubMed 23208766

https://www.ncbi.nlm.nih.gov/pubmed/23208766 (öffnet neues Fenster)

Prostaglandin E2 analogue sulprostone for treatment of atonic postpartum hemorrhage. (öffnet neues Fenster)

Schmitz T, Tararbit K, Dupont C, Rudigoz RC, Bouvier-Colle MH, Deneux-Tharaux C; Pithagore6 Group.

Quelle‎: Obstet Gynecol 2011;118(2 Pt 1):257-65.

Indiziert‎: PubMed 21775840

DOI‎: 10.1097/AOG.0b013e3182255335

https://www.ncbi.nlm.nih.gov/pubmed/21775840 (öffnet neues Fenster)

The effects of a peripartum strategy to prevent and treat primary postpartum haemorrhage at health facilities in Niger: a longitudinal, 72-month study. (öffnet neues Fenster)

Seim AR, Alassoum Z, Souley I, Bronzan R, Mounkaila A, Ahmed LA

Quelle‎: Lancet Glob Health. 2023 11(2):e287-e295.

Indiziert‎: PubMed 36669809

DOI‎: 10.1016/S2214-109X(22)00518-6.

https://pubmed.ncbi.nlm.nih.gov/36669809/ (öffnet neues Fenster)

Intravenous sulprostone infusion in the treatment of retained placenta. (öffnet neues Fenster)

Stefanovic V, Paavonen J, Loukovaara M, Halmesmäki E, Ahonen J, Tikkanen M.

Quelle‎: Acta Obstet Gynecol Scand 2013;92(4):426-32.

Indiziert‎: PubMed 22862433

DOI‎: 10.1111/j.1600-0412.2012.01506.x

https://www.ncbi.nlm.nih.gov/pubmed/22862433 (öffnet neues Fenster)

Carbetocin for preventing postpartum haemorrhage. (öffnet neues Fenster)

Su LL, Chong YS, Samuel M.

Quelle‎: Cochrane Database Syst Rev 2012;(4):CD005457.

Indiziert‎: PubMed 22513931

https://www.ncbi.nlm.nih.gov/pubmed/22513931 (öffnet neues Fenster)

Prostaglandins for preventing postpartum haemorrhage. (öffnet neues Fenster)

Tunçalp Ö, Hofmeyr GJ, Gülmezoglu AM.

Quelle‎: Cochrane Database Syst Rev 2012;(8):CD000494.

Indiziert‎: PubMed 22895917

DOI‎: 10.1002/14651858.CD000494.pub4

https://www.ncbi.nlm.nih.gov/pubmed/22895917 (öffnet neues Fenster)

Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage. (öffnet neues Fenster)

Westhoff G, Cotter AM, Tolosa JE.

Quelle‎: Cochrane Database Syst Rev 2013;(10):CD001808.

Indiziert‎: PubMed 24173606

DOI‎: 10.1002/14651858.CD001808.pub2

https://www.ncbi.nlm.nih.gov/pubmed/24173606 (öffnet neues Fenster)